Australia’s iNova Picks Singapore As Perch For Southeast Asia Branded Generics M&A
This article was originally published in PharmAsia News
Executive Summary
Australia’s iNova Pharmaceuticals will move its executive suite and distribution operations for Asia to Singapore, seeking to use the city state as a hub to scout out M&A opportunities in Southeast Asia focused on branded generics.